Home » Topics » Disease categories and therapies » Urology

Urology
RSS

New treatment options for urological disorders reported in recent patents

Nov. 11, 2008

Amitriptyline beneficial in benign prostatic hyperplasia

Nov. 4, 2008

FDA approves fesoterodine for overactive bladder

Nov. 3, 2008

FDA approves Kringle's IND to initiate phase I trial of recombinant human HGF in ARF

Nov. 3, 2008

Tamsulosin-tolterodine ER combination improves ureteral stent-related urinary symptoms

Nov. 3, 2008

Questcor evaluates Acthar as potential new treatment for nephrotic syndrome

Oct. 29, 2008

Flupirtine mechanism of action may be useful in treating overactive bladder

Oct. 29, 2008

Recent Takeda patent reports new 5-HT2C receptor agonists for urinary incontinence

Oct. 15, 2008

Protox presents positive 12-month data from BPH study

Oct. 10, 2008

Watson receives FDA approval for Rapaflo for benign prostatic hyperplasia

Oct. 9, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...